Evaluation of the Causes and Disease Processes of Chronic Lung Disease

NCT00001183 | Completed

• 2 other identifiers: 82003282-H-0032
• Study Type: observational
• Target: 6,564
• Locations: 1 country
• Sites: 1

Brief Summary

Chronic lung diseases are disorders associated with abnormalities in any of the structures involved in the process of breathing and bringing oxygen into the lungs and blood. This includes abnormalities in the airways, lungs, blood vessels in and around the lungs, and the tissue covering the lungs (pleura). The purpose of this research study is to evaluate patients referred to the Cardiovascular and Pulmonary Branch of the National Heart, Lung, and Blood Institute (NHLBI) in order to;

1. 1.Develop a better understanding of the causes and disease processes involved in disorders of the lungs
2. 2.Identify patients eligible to participate in other P-CCMB research studies

Conditions

Pulmonary Disease

Keywords

Computed Tomography; Fiberoptic Bronchoscopy; Pulmonary Function Testing; Cardiopulmonary Exercise Testing; Allergen Skin Testing

Outcome Measures

Primary Outcomes (1)

• N/A-screening protocol

  Evaluate

  1 Visit

Study Arms (1)

Group 1

Pulmonary Patients

Eligibility Criteria

• Age: 7 Years - 90 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

patients being screened for lung disease

You may qualify if:

• Symptoms consistent with pulmonary disease.
• May have family history of lung disease.
• Patients with diseases of organs with known association with lung disease.
• Ranging in age from 7 to 90 years old.
• Pregnant and nursing women may participate in minimal risk procedures

You may not qualify if:

• Persons with no clinical evidence of lung disease.

Sponsors & Collaborators

• National Heart, Lung, and Blood Institute (NHLBI): lead

Study Sites (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, Maryland, 20892, United States

Location

Related Links

• NIH Clinical Center Detailed Web Page

MeSH Terms

Conditions

Lung Diseases

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases

Study Officials

• Joel Moss, M.D.

  National Heart, Lung, and Blood Institute (NHLBI)

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: NIH
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 3, 1999
• First Posted: November 4, 1999
• Study Start: November 18, 1984
• Primary Completion: December 16, 2019
• Study Completion: December 16, 2019
• Last Updated: June 1, 2022

Record last verified: 2022-05

Locations

US (1)